share_log

JMP Securities Maintains Market Outperform on Macrogenics, Lowers Price Target to $8

JMP Securities Maintains Market Outperform on Macrogenics, Lowers Price Target to $8

JMP證券仍然對MacroGenics保持強勁表現,但將價格目標下調至8美元
Benzinga ·  07/31 14:16  · 評級/大行評級

JMP Securities analyst Silvan Tuerkcan maintains Macrogenics (NASDAQ:MGNX) with a Market Outperform and lowers the price target from $16 to $8.

JMP證券的分析師Silvan Tuerkcan認爲,Macrogenics(納斯達克:MGNX)的市場表現仍然強勁,並將目標價格從16美元調低至8美元,仍持有買入評級。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論